Hal Chapman
Clinical trials sponsored by Hal Chapman, explained in plain language.
-
Green tea extract studied as possible IPF treatment
Symptom relief CompletedThis study tested the safety of a purified green tea extract called EGCG in 50 people with idiopathic pulmonary fibrosis (IPF), a serious lung disease. Participants took EGCG or a placebo daily for 12 weeks. The main goal was to see if EGCG is safe and how it interacts with stand…
Phase: PHASE1 • Sponsor: Hal Chapman • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Green tea extract under the PET scanner: can we see it fight lung scarring?
Knowledge-focused CompletedThis study tested whether a special PET scan can detect changes in lung collagen (scar tissue) in people with idiopathic pulmonary fibrosis (IPF) after taking a green tea extract called EGCG. Twelve participants from a larger EGCG study received the PET scan before and after trea…
Phase: PHASE1 • Sponsor: Hal Chapman • Aim: Knowledge-focused
Last updated May 26, 2026 12:02 UTC